Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years. Further, recent studies suggest that mesenchymal stem cells mesenchymal stem cells can be effectively used to improve patients' resistance to the SARS-CoV-2 virus induced pneumonia leading to speedy recovery.

 

To order this 500+ page report, which features 185+ figures and 220+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html

 

The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:

Source of stem cell

Allogeneic

Autologous

Origin of stem cell

  • Adult
  • Embryonic
  • Type of stem cell
  • Hematopoietic
  • Mesenchymal
  • Progenitor
  • Others

Lineage of stem cell

Adipose Tissue

Bone Marrow

Cord Blood

Others

Route of Administration

Intraarticular

Intracoronary

Intramuscular

Intramyocardial

Intrathecal

Intravenous

Surgical Implantations

Others

Therapeutic Area

Autoimmune / Inflammatory Disorder

Cardiovascular Disorders

Metabolic Disorder

Musculoskeletal Disorders

Oncological Disorders

Neurological Disorders

Ophthalmic Disorders

Others

End Users

Ambulatory Surgery Centers

Hospitals

Specialty Clinics

Key Geographies

North America

Europe

Asia-Pacific and Rest of the World

The Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”. report features the following companies, which we identified to be key players in this domain: 

  • Anterogen
  • Athersys
  • CHABiotech
  • Cytopeutics
  • Hope Biosciences
  • Japan Regenerative Medicine
  • Lineage Cell Therapeutics
  • Orchard Therapeutics
  • Osiris Therapeutics
  • Pluristem Therapeutics
  • Promithera Biosciences
  • Regenexx
  • Stempeutics Research
  • SCM Life Sciences

TICEBA

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Profiles

6. Key Therapeutic Areas

7. Assessment of Relative Competition and Growth Opportunities

8. Academic Grants Analysis

9. Clinical Trail Analysis 

10. Stem Cell Manufacturing Market Landscape and KPIs for Evaluating Contract

Services Partners

11. Stem Cell Therapy Developers and CMOs: Opportunity Assessment

12. Key Commercialization Strategies

 

13. Market Forecast

14. Conclusion 

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe